Cell Therapeutics files 2009 Annual Report on Form 10-K

Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) today announced that it has filed its Annual Report on Form 10-K for the year ended December 31, 2009 (the "Annual Report on Form 10-K"). This filing is available for review on CTI's website at www.CellTherapeutics.com, or on the Securities and Exchange Commission's website at www.sec.gov.

As required under NASDAQ Marketplace Rule 5250(b)(2), CTI also announced that its consolidated financial statements for the fiscal year ended December 31, 2009, included in the Annual Report on Form 10-K, contained a "going concern" qualification from its independent registered public accounting firm.  This announcement does not represent any change or amendment to CTI's fiscal year 2009 financial statements or to its Annual Report on Form 10-K.

SOURCE Cell Therapeutics, Inc.